The following is a summary of “Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study,” published in the September 2024 issue of ...

After an in-depth analysis of the genetic material from hundreds of swabs taken from the walls, floors, machines and drains ...

Researchers from Weill Cornell Medicine have used a cutting-edge model system to uncover the mechanism by which SARS-CoV-2, the virus that causes COVID-19, induces new cases of diabetes, and worsens ...

Researchers have discovered an antibody able to neutralize all known variants of SARS-CoV-2, the virus that causes COVID-19, as well as distantly related SARS-like coronaviruses that infect other ...

Scientists at the University of Minnesota and the Midwest Antiviral Drug Discovery (AViDD) Center have made a surprising ...

Since the start of the COVID-19 pandemic, the virus that causes the illness - SARS-CoV-2 - has had innumerable opportunities to mutate and change, and the virus has certainly taken advantage of those ...

Published in the journal PLOS Pathogens, this study is the first to identify an antibody that can both assist and block the virus.

Autoimmune disorders like lupus often involve overactivation of the interferon pathway, Landegren says. These disorders are ...

A mutation on the spike protein of the virus that causes COVID-19 could help it infect the brain by forcing it to use a cellular "back door." SARS-CoV-2, the virus that causes COVID-19 ...

The U.S. is coming down from its biggest COVID summer surge yet as a new subvariant emerges—but new vaccines are here, too.

Starting antiviral treatment as late as 14 days after infection with SARS-CoV-2 may still be beneficial in hosts with compromised immune systems, who are at greatest risk of developing severe COVID-19 ...